Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
- IGT Tied to Increased Mortality
- A Dietary Approach to Managing Type 2 Diabetes
- Uncovering the Cardiovascular Effects of Pioglitazone
- Understanding the Risks: Incretin-based Therapy
- Research Team Uses Gene Sequencing to Solve 85-year-old Diabetes Mystery
- Exclusive: Dr. Denise Faustman on the Search for a Cure
Sometimes, when we want to impress our patients with the importance of their disease, we will list all the possible effects of the disease. These include blindness, kidney failure, and amputations. But what do we tell our patients that have pre-diabetes or impaired glucose tolerance? This week, we have an item on the effects of IGT on mortality. The data makes a very good commentary to share with your patients.
*****************************
We can make a difference!
*****************************
Dave Joffe, Editor-in-chief
This Week's Survey
When the Biosimilar insulin to Lantus becomes available for about 10-15% less cost, will you recommend it to your patients? Follow the link to share your opinion!
Newsflash:
New biosimilar: Lilly has a biosimilar to Lantus, and now Merck is also submitting their biosimilar to the FDA.
Tool for Your Practice
Free program for your newly diagnosed patients!
Let the American Diabetes Association help you answer some of the many questions your patients have at diagnosis. It all starts with a free booklet for you to give your patients with the information they need on day 1. The booklet also offers them the opportunity to enroll in a free, year-long program to get ongoing information, tools, recipes and support to help them manage and live well with diabetes. Order your free booklets today.
Test Your Knowledge
Weight loss has been shown to have a positive impact on glucose control and cardiovascular risk factors. At which weight loss threshold do these positive benefits start to become meaningfully apparent?
A) Weight reduction of 0-4%
B) Weight reduction of 5-10%
C) Weight reduction of 11-15%
D) Weight reduction of 16-20%
Did you get it right? Follow the link to find out!
Fact:
Average American 15 Pounds Heavier Than 20 Years Ago: Growing wider but not taller, research shows. The new statistics were released Aug. 3 in a report from the U.S. Centers for Disease Control and Prevention’s National Center for Health Statistics. The statistics for 2011-2014 are based on an analysis of a sample of 19,151 people.
According to the report, the average weight in the United States rose from 181 pounds to 196 pounds between 1988-1994 and 2011-2014 for men, and from 152 pounds to 169 pounds for women, with no change in average height for either group. When looked at by race, blacks gained the most on average. In 11-year-old children, girls are more than seven pounds heavier with no change in height; boys gained an inch in height, but 13.5 pounds in weight compared to two decades ago.
A 15- to 16-pound weight gain is fairly significant and typically would be consistent with a couple of points increase in body mass index. Increasing BMI is a good indicator of overall risk for a variety of diseases, including heart disease and diabetes. As our BMIs go up so does the risk for more heart disease, cancer and diabetes. Such an increase does not bode well for the overall health of the nation.
David Katz, M.D., M.P.H., director, Yale University Prevention Research Center, and president, American College of Lifestyle Medicine, New Haven, Conn.; Anthony Comuzzie, Ph.D., scientist, department of genetics, Texas Biomedical Research Institute, San Antonio; Aug. 3, 2016, Anthropometric Reference Data for Children and Adults: United States, 2011-2014 National Center for Health Statistics report, U.S. Centers for Disease Control and Prevention
A study in Diabetes Care showed that 74.7% of deaths among patients with impaired glucose tolerance happened after progression to type 2 diabetes.
Adopting a Mediterranean diet in patients with diabetes helps improve glucose levels.
Is pioglitazone a viable option for patients with insulin resistance and recent stroke or myocardial infarction?
Can DPP-4 inhibitors and GLP-1 analogues cause bile duct and gallbladder complications?
A team of researchers at the University of Wisconsin School of Medicine and Public Health has identified the genetic cause for a rare syndrome in children with poorly controlled type 1 diabetes.
Exclusive Interview Transcript: Denise Faustman, M.D., Ph.D.
In part 1 of this exclusive interview, Dr. Faustman discusses her research and why an old tuberculosis vaccine may lead us to a cure for type 1.
In part 2 of this exclusive interview, Dr. Faustman discusses the challenges of dosing BCG correctly, and the difficulties of defeating autoimmunity in humans.
In part 3 of this exclusive interview, Dr. Faustman discusses how a cure based on the inexpensive BCG vaccine could permanently change type 1 treatment, and whether results could also apply to type 2.
Quote of the Week!
“Setting goals is the first step in turning the invisible into the visible.”
…Tony Robbins
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com